Fig. 1 · Structure

Documents & Downloads

Capsaicin

Cat. No. A10178 CAS 404-86-4
Capsaicin is an active component of chili peppers, which are plants belonging to the genus Capsicum.

In Stock

Publications for Capsaicin

6 publications citing this product

  1. Thieu X Phan, .et al. , J Physiol, 2022, Apr;600(7):1651-1666 PMID: 35020949
  2. Xiao-Yan Liu, .et al. , Sci Rep, 2022, 12: 11996 PMID: 35835852
  3. Thieu X. Phan, .et al. , bioRxiv, 2021, February 27
  4. Thieu X Phan, .et al. , J Physiol, 2020, Sep 17 PMID: 32944976
  5. Jun Hai, .et al. , Biosci Biotechnol Biochem, 2020, Jul 7;1-7 PMID: 32633621
  6. Thieu X. Phan, .et al. , bioRxiv, 2020, February 04

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Bioactivity / Mechanism

Capsaicin activates TRPV1-dependent calcium signaling. In isolated mouse cerebellar arterioles, 1 μM capsaicin increased calcium signals in wild-type tissue, whereas TRPV1-null tissue lacked the response despite retaining KCl responsiveness. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Cellular Effect

Cell Line Activity Value Description Reference
A2058 IC50 > 100 μM Cytotoxicity against human A2058 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay [PMID: 31104785]
B16-F10 IC50 > 100 μM Cytotoxicity against mouse B16F10 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay [PMID: 31104785]
BGC-823 IC50 4.659 μM Antiproliferative activity against human BGC-823 cells assessed as reduction in cell viability incubated for 5 days by MTS assay [PMID: 33581557]
CHO EC50 25.9 nM Agonist activity at human TRPV1 expressed in CHO cells assessed as increase in 45Ca2+ uptake incubated for 5 mins by liquid scintillation counting method [PMID: 31702924]
CHO EC50 44.8 nM Agonist activity at rat TRPV1 expressed in CHO cells assessed as increase in 45Ca2+ uptake incubated for 5 mins by liquid scintillation counting method [PMID: 31702924]
CHO EC50 44.8 nM In vitro [Ca2+] influx relative to capsaicin by Rat Vanilloid receptor (VR1) expressing CHO cells [PMID: 12825950]
HBMEC-2 EC50 16.37 μM Neuroprotective activity against H2O2-induced cell damage in human HBMEC2 cells assessed as increase in cell viability preincubated for 24 hrs followed by H2O2 addition and measured after 4 hrs by MTT assay [PMID: 31541868]
HCT-116 IC50 40.16 μM Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition measured after 72 hrs by crystal violet staining based assay [PMID: 34795858]
HEK293 EC50 0.0039 μM Agonist activity at human TRPV1 ion channel expressed in HEK293 cells assessed as calcium influx by fluo-4-Am-based fluorimetry [PMID: 22257892]
HEK293 EC50 0.0053 μM Agonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as Ca2+ influx by Fluo-4 dye based assay [PMID: 25666822]
HEK293 IC50 0.008 μM Antagonist activity against human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsaicin-induced Ca2+ influx pre-treated 5 mins before capsaicin addition by Fluo-4 dye based assay [PMID: 25666822]
HeLa IC50 > 50 μM Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay [PMID: 29685681]
K562 IC50 49.41 μM Antiproliferative activity against human K562 cells after 48 hrs by MTT assay [PMID: 29685681]
MCF7 IC50 100 μM Antiproliferative activity in human MCF7 cells assessed as cell growth inhibition by MTT assay [PMID: 33508189]
MCF7 IC50 49.97 μM Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay [PMID: 29685681]
MDA-MB-231 IC50 120 μM Antiproliferative activity against human MDA-MB-231 cells incubated for 24 hrs by MTT assay [PMID: 32686940]
NCI-H460 IC50 30.66 μM Antiproliferative activity against human NCI-H460 cells assessed as cell growth inhibition measured after 72 hrs by crystal violet staining based assay [PMID: 34795858]
SH-SY5Y EC50 14.02 μM Neuroprotective activity against H2O2-induced cell damage in human SH-SY5Y cells assessed as increase in cell viability preincubated for 24 hrs followed by H2O2 addition and measured after 4 hrs by MTT assay [PMID: 31541868]
SH-SY5Y EC50 2.32 μM Agonist activity at rat TRPV1 expressed in human SH-SY5Y cells assessed as intracellular calcium accumulation by Fluo-4 NW dye based fluorescence assay [PMID: 30783490]

19 records · Scroll to view more

Capsaicin Research Summary

This section summarizes 2 in vitro studies and 1 in vivo study of Capsaicin from 2 published references. In vitro models include isolated cerebellar arteries from wild-type and TRPV1-null mice.

Capsaicin In Vitro Studies

Vascular responses depend on the preparation. In cultured primary rat aortic smooth muscle cells, 10 μmol/L capsaicin for 15 minutes produced no relevant calcium increase under either serum-starved or supplemented conditions; ionomycin remained effective. [2]

TRPV1-dependent calcium signaling in isolated mouse arterioles

Cell-based study · Isolated cerebellar arteries from wild-type and TRPV1-null mice. [1]

Capsaicin increased calcium signaling in wild-type arteries; the corresponding response was absent in TRPV1-null arteries. KCl responses provided a depolarization control. This experiment supports functional TRPV1-dependent signaling in the tested vascular preparation.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Capsaicin-evoked calcium signaling: wild-type response versus TRPV1-null; KCl response preserved.Genotype comparison P = 0.00013 (Results); n = 40–70 cells in the groups from three independent experiments (caption).[1]

Literature-Reported Treatment Conditions

Treatment concentration
Capsaicin 1 μM; KCl 50 mM control.
Method
Acute bath challenge during Fluo-4-AM calcium imaging at 32–33°C.
Vehicle
Capsaicin stock prepared in ethanol; final ethanol fraction for this assay not specified in the read methods.
Co-treatment
No combination-efficacy claim; KCl is a control challenge.
Reported limits
Exact capsaicin exposure duration and final solvent fraction not specified for these panels; no EC50 determination.
Methods and source locations

Compound reported in the paper: Capsaicin; Compound label in the paper: Capsaicin

Findings concern the reported research reagent; they do not validate an Adooq lot or a clinical patch formulation. Exact stereochemical purity was not established.

Figure 5A–D; Results, TRPV1 in arteries is restricted to vascular smooth muscle; Methods, Ca2 imaging and Chemicals

Capsaicin-evoked calcium signaling: wild-type response versus TRPV1-null; KCl response preserved.: Fluo-4-AM imaging; unpaired t test. General statistical methods report means ± SD. No curve-derived decimal values extracted. — Figure 5A–D and caption; Results paragraph immediately preceding Figure 5

No capsaicin-evoked calcium increase in cultured rat aortic cells

Cell-based study · Commercial primary rat aortic vascular smooth muscle cells, passages 4–12; serum-starved and normally serum-supplemented cultures. [2]

Capsaicin did not elicit a relevant calcium increase in either culture condition. Ionomycin elicited a strong response, supporting technical responsiveness. This limits generalization from small native arterioles to cultured aortic smooth muscle.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
No relevant capsaicin-evoked intracellular calcium increase in starved or non-starved primary VSMCs; ionomycin response present.Qualitative calcium response Capsaicin: n = 549 starved cells and n = 898 non-starved cells; extracellular-solution controls: n = 534 and 597 cells. Time courses shown as mean ± SD.[2]

Literature-Reported Treatment Conditions

Treatment concentration
Capsaicin 10 μmol/L; ionomycin 2 μmol/L positive control.
Exposure duration
15 min capsaicin exposure.
Method
Fura-2 AM calcium microfluorimetry during continuous superfusion; F340/F385 ratio.
Vehicle
Extracellular solution comparison; capsaicin stock solvent/final solvent fraction not specified for this calcium assay in the read methods.
Co-treatment
Ionomycin added at the end as a technical positive control; no combination-efficacy inference.
Reported limits
Serum-deprivation duration for this calcium experiment and independent biological replicate count are not specified in the Figure 3 caption; reported n denotes cells.
Methods and source locations

Compound reported in the paper: Capsaicin; Compound label in the paper: Capsaicin

Findings concern the reported research reagent; they do not validate an Adooq lot or a clinical patch formulation. Exact stereochemical purity was not established.

Figure 3A–D and caption; Results, Lack of functional expression of TRPV1 in rat aortic VSMCs; Methods, Materials, Cell culture and Calcium microfluorimetry

No relevant capsaicin-evoked intracellular calcium increase in starved or non-starved primary VSMCs; ionomycin response present.: Fura-2 AM ratio imaging, 15-minute exposure. Cell counts read directly from panel labels; no numerical response amplitude inferred from curves. — Figure 3A–D image/caption; Results, Lack of functional expression of TRPV1 in rat aortic VSMCs

Capsaicin In Vivo Studies

Intravenous capsaicin acutely raised blood pressure in wild-type mice, with no corresponding response in TRPV1-null mice. Rat experiments showed dose-dependent pressor effects together with an early transient fall in pressure and heart rate. These model-specific acute effects do not establish chronic cardiovascular benefit. [1]

Acute systemic blood-pressure responses to intravenous capsaicin

Animal study · Anaesthetized wild-type and TRPV1-null mice; anaesthetized rats. [1]

Capsaicin evoked a marked pressor response in wild-type mice that was absent in TRPV1-null mice. Rat dose-response experiments also showed an early transient depressor/bradycardic phase, followed at higher doses by a pressor response. These acute responses do not establish chronic blood-pressure or therapeutic effects.

Conditions shared by the study groups

Treatment course
Acute recording
Vehicle
Saline with 0.4% ethanol
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Wild-type versus TRPV1-null mouse response
32 μg/kg
Pre-infusion baseline and TRPV1-null genotype.Reported BP rise approximately 45 mmHg in wild-type mice; no capsaicin response in TRPV1-null mice. Peak HR did not change significantly. Caption n = 4–7; unpaired t test.[1]
Rat dose-response and early reflex
2, 4, 8, 16 and 32 μg/kg in early-reflex experiments; Fig. 9D summarizes pressor responses at 4–32 μg/kg.
Pre-dose baseline; Fig. 10 includes atropine pretreatment and sensory-nerve-ablated comparisons.Highest tested dose produced approximately 60 mmHg systolic/diastolic BP rise. An early transient BP fall and bradycardia occurred; atropine or nerve ablation eliminated the transient depressor response. Caption n = 6; one-way ANOVA.[1]
Wild-type versus TRPV1-null mouse response
Model: Anaesthetized mice; urethane 1.2–1.5 g/kg i.p. per shared Methods.
Route: Intravenous infusion
Frequency: 20 s infusion
Reported limits: The n range applies to Fig. 9A–C; group-specific n not separately assigned here.
Rat dose-response and early reflex
Model: Anaesthetized rats; thiopental 50 mg/kg i.p. per shared Methods.
Route: Intravenous bolus
Frequency: Escalating bolus challenges; re-administration only after stable BP/HR baseline
Reported limits: Exact interval between escalating doses and atropine dose not specified in these adopted locations. No nerve-ablation dosing protocol is extracted.
Methods and source locations

Compound reported in the paper: Capsaicin; Compound label in the paper: Capsaicin

Findings concern the reported research reagent; they do not validate an Adooq lot or a clinical patch formulation. Exact stereochemical purity was not established.

Figure 9A–E and Figure 10A–C; Results, Arterial TRPV1 regulates systemic blood pressure; Methods, systemic BP recording and Drug administration

Wild-type versus TRPV1-null mouse response · Figure 9A–C image/caption; Results, Arterial TRPV1 regulates systemic blood pressure; Methods, systemic BP recording

Rat dose-response and early reflex · Figure 9D–E and Figure 10A–C images/captions; Results, Arterial TRPV1 regulates systemic blood pressure; Methods, Drug administration

Specifications

Manufacturer Adooq Bioscience
CAS Number 404-86-4
Formula C18H27NO3
Molecular Weight 305.4
Synonyms Qutenza; Vanilloid
SMILES
CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 55 mg/mL (180.08 mM)
Water Insoluble
Ethanol 55 mg/mL (180.08 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Capsaicin Research References

  1. [1] Phan TX, Ton HT, Gulyás H, et al. TRPV1 expressed throughout the arterial circulation regulates vasoconstriction and blood pressure The Journal of physiology (2020). PMID: 32944976 DOI: 10.1113/jp279909 Source material
  2. [2] Blažević T, Ciotu CI, Gold-Binder M, et al. Cultured rat aortic vascular smooth muscle cells do not express a functional TRPV1 PloS one (2023). PMID: 36787302 DOI: 10.1371/journal.pone.0281191 Source material

Publications

6 publications citing this product

  1. Thieu X Phan, .et al. , J Physiol, 2022, Apr;600(7):1651-1666 PMID: 35020949
  2. Xiao-Yan Liu, .et al. , Sci Rep, 2022, 12: 11996 PMID: 35835852
  3. Thieu X. Phan, .et al. , bioRxiv, 2021, February 27
  4. Thieu X Phan, .et al. , J Physiol, 2020, Sep 17 PMID: 32944976
  5. Jun Hai, .et al. , Biosci Biotechnol Biochem, 2020, Jul 7;1-7 PMID: 32633621
  6. Thieu X. Phan, .et al. , bioRxiv, 2020, February 04

Added to your cart

View Cart Checkout
Loading...